Colorectal Neuroendocrine Tumor G1

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Colorectal Neuroendocrine Tumor G1 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 3

NCT00569127

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Adv…

This randomized phase III trial studies octreotide acetate and recombinant interferon alfa-2b to see how well it works compared to octreotide acetate and bevaci…

United States427 participantsStarted 2007-12-01

Treatment: Bevacizumab, Laboratory Biomarker Analysis